RxDoctor Payments DataLook up a doctor →

Duccio Baldari, MD

Cardiovascular Disease · Wellington, FLNPI 1992786503

Payments from drug & device makers

$3,503,529in general payments, 2019–2025

Across 1,637 payments — averaging $2140.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$1.3M
  • American Regent$917K
  • CSL Behring$703K
  • Eisai Inc.$257K
  • Johnson & Johnson$130K
  • Amgen$57K
  • plus $152K from 53 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis182$1,287,360
American Regent20$917,102
CSL Behring133$703,352
Eisai Inc.3$257,102
Johnson & Johnson433$129,524
Amgen153$56,708
Boehringer Ingelheim Pharma GmbH & Co.kg3$39,037
Boehringer Ingelheim International GmbH10$37,677
Bayer34$36,695
Astrazeneca UK Limited1$8,745
Alnylam Pharmaceuticals Inc.5$8,647
Novo Nordisk12$4,994
Eli Lilly1$2,447
Boehringer Ingelheim105$2,135
E.r. Squibb & Sons, L.L.C.198$2,123
Medtronic(2 entities)25$1,711
Cvrx, Inc.38$889
Bard Peripheral Vascular, Inc.25$685
Abbott15$607
Pfizer34$537
Merck25$463
Boston Scientific12$414
AstraZeneca18$378
Kestra Medical Technology Services, Inc.9$318
Esperion Therapeutics, Inc.14$317
Abiomed5$276
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)17$271
Astellas Pharma US Inc5$265
Biosense Webster, Inc.5$247
Sanofi-aventis U.S. LLC13$232
Amarin Pharma, Inc.15$227
Impulse Dynamics (USA) Inc.3$214
Shockwave Medical, Inc3$200
Chiesi USA, Inc.7$200
Philips North America LLC2$191
Atricure, Inc.3$182
Cleerly, Inc.3$170
Edwards Lifesciences2$100
Cook Medical LLC6$82
Heartflow, Inc.3$72
Kiniksa Pharmaceuticals International, PLC3$70
Lexicon Pharmaceuticals, Inc.3$60
Cardiva Medical, Inc.2$57
Cardiovascular Systems Inc.7$52
Kvk-tech, Inc.4$49
Kiniksa Pharmaceuticals, Ltd.2$43
Scpharmaceuticals Inc.2$42
Kowa Pharmaceuticals America, Inc.2$37
Inari Medical, Inc.1$27
Penumbra, Inc.1$25
G Medical Diagnostic Services, Inc.2$23
Braemar Manufacturing, LLC1$21
AbbVie1$21
Cordis US CORP.1$20
Analog Devices Inc.1$20
Inspire Medical Systems, Inc.1$18
Lilly USA, LLC1$18
Bardy Diagnostics, Inc.1$15
Agepha Pharma FZ LLC1$15

How this compares

$3,503,529 in reported general payments places this provider in the 95th percentile of 1,740 cardiovascular disease providers in Florida.

See all cardiovascular disease providers in Florida →

Medicare billing

Part B allowed, 2024
$484,753
Medicare patients
706
Services billed
4,243

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Wellington

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →